Recalls / Class II
Class IID-0121-2016
Product
SERMORELIN/GHRP-6/GHRP-2, Injectable Solution, 9/5.4/5.4MG/9ML, 9mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Affected lot / code info
- t10062014@19, t09152014@13, t08262014@1, t08072014@20, t05282015@28, t03062015@14, t02162015@26, 12222014@3, 11262014@6, 11172014@4, 11052014@3, 10272014@7, 10222014@23, 10202014@20, 10152014@5, 10012014@17, 09102014@3, 08182014@9, 07222014@31, 06292015@10, 06232014@3, 06222015@6, 05132015@7, 05062015@7, 05042015@4, 04272015@8, 04222015@6, 03302015@11, 03252015@9, 02202015@24, 01232015@20, 01192015@1, 01052015@8.
Why it was recalled
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Recalling firm
- Firm
- JD & SN Inc., dba Moses Lake Professional Pharmacy
- Notification channel
- Press Release
- Type
- Voluntary: Firm initiated
- Address
- 1555 Pilgrim St, N/A, Moses Lake, Washington 98837-4623
Distribution
- Quantity
- 165 syringes
- Distribution pattern
- Nationwide
Timeline
- Recall initiated
- 2015-07-24
- FDA classified
- 2015-10-27
- Posted by FDA
- 2015-11-04
- Terminated
- 2016-04-13
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0121-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.